Lopinavir functions as a potent protease inhibitor for viral management. Viral replication cycles are terminated when the substance prevents the cleavage of necessary precursor polyproteins within infected host cells.
Lopinavir belongs to a group of antiviral compounds known as protease inhibitors. It is designed to interfere with a specific step in the life cycle of certain viruses, helping the immune system keep the infection under control. The molecule is most widely recognized as the active component of the combination product Kaletra, which is marketed in Singapore for viral therapy. In everyday language, this substance is often described as the “active part” that gives the medication its therapeutic effect.
Kaletra pairs Lopinavir with a low-dose booster called ritonavir, allowing the drug to stay in the bloodstream longer. The combination is supplied as tablets that patients swallow whole, and the dosage strength is standardized across the Singapore market. While Kaletra is the most common brand, generic versions of the same Lopinavir/ritonavir blend are also available under various local names. Both brand-name and generic options contain the same active ingredient, though packaging and labeling may differ.
Lopinavir is primarily used to manage infections caused by HIV, the virus that attacks the immune system. It helps reduce the amount of virus circulating in the blood, which can slow disease progression. The medication is also sometimes considered in clinical studies for other viral illnesses, but its main role remains HIV treatment. Adults and adolescents with confirmed infection may receive Lopinavir-based regimens, while pediatric formulations are adapted to suit younger patients.
When a virus replicates, it produces an enzyme that cuts large protein pieces into smaller, functional components. Lopinavir binds to this enzyme, preventing it from completing the cutting process. Without the correctly formed proteins, new virus particles cannot assemble properly, which limits the spread of infection. This mechanism does not involve the immune system directly, making Lopinavir a targeted antiviral tool.
For precise interaction details, refer to the specific medication’s product information.
Store tablets in a dry place away from direct sunlight and keep them out of reach of children. The typical treatment course can be short-term during the initial phase of therapy or continue long-term if viral suppression is the goal. Different formulations of Kaletra may have slight variations in tablet size or coating, but the core active substance remains the same. For detailed dosing instructions, always check the label accompanying the medication you are using.
This article offers an educational overview of Lopinavir as an active substance and does not constitute medical advice. Individual medicines containing this component, such as Kaletra, may differ in strength, formulation, and guidance for use. The information provided here carries no liability for clinical decisions. Patients should read the labeling of their specific product and seek guidance from a qualified healthcare professional when needed.
